Abbvie Inc (ABBV)
206.71 x 300 209.78 x 1,200
Post-market by (Cboe BZX)
209.17 -0.84 (-0.40%) 03/24/25 [NYSE]
206.71 x 300 209.78 x 1,200
Post-market 209.14 -0.03 (-0.01%) 18:46 ET
for Mon, Mar 24th, 2025
Results
download Want to compare other data? Select FieldsSymbol | ABBV | LLY | JNJ | NVO | MRK |
Company | Abbvie Inc | Eli Lilly and Company | Johnson & Johnson | Novo Nordisk A/S ADR | Merck & Company |
Price Information | |||||
Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
Open | 209.39 | 845.32 | 162.84 | 74.97 | 92.90 |
High | 211.02 | 866.87 | 164.39 | 76.00 | 93.11 |
Low | 207.50 | 837.76 | 162.50 | 74.90 | 91.56 |
Last | 209.17 | 864.90 | 163.29 | 75.33 | 92.31 |
Change | -0.84 | +27.33 | -0.34 | -1.53 | -0.80 |
% Change | -0.40% | +3.26% | -0.21% | -1.99% | -0.86% |
Volume | 7,393,700 | 3,102,300 | 8,046,500 | 8,083,100 | 16,950,100 |
20-Day Average Volume | 7,012,335 | 3,771,370 | 9,561,540 | 7,165,105 | 17,488,855 |
Previous Close | 210.01 | 837.57 | 163.63 | 76.86 | 93.11 |
Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 210.72 | 865.78 | 164.52 | 82.97 | 93.37 |
20-Day Raw Stochastic | 44.92% | 49.57% | 24.63% | 7.65% | 40.54% |
20-Day Relative Strength | 59.72% | 53.55% | 56.69% | 38.70% | 47.09% |
Weighted Alpha | +20.29 | +9.57 | +6.07 | -46.81 | -30.14 |
Today's Opinion | 88% Buy | 24% Buy | 56% Buy | 100% Sell | 80% Sell |
Previous Opinion | 88% Buy | 8% Sell | 56% Buy | 88% Sell | 96% Sell |
Last Month's Opinion | 56% Buy | 24% Buy | 40% Buy | 80% Sell | 100% Sell |
Performance | |||||
5-Days | |||||
%Chg | -2.47% since 03/17/25 | +4.87% since 03/17/25 | +0.28% since 03/17/25 | -6.01% since 03/17/25 | -2.62% since 03/17/25 |
Low | 207.50 on 03/24/25 | 812.61 on 03/18/25 | 161.93 on 03/20/25 | 74.89 on 03/24/25 | 91.56 on 03/24/25 |
High | 215.18 on 03/18/25 | 866.87 on 03/24/25 | 164.86 on 03/18/25 | 82.57 on 03/18/25 | 95.43 on 03/19/25 |
1-Month | |||||
%Chg | +2.49% since 02/24/25 | -1.87% since 02/24/25 | -0.27% since 02/24/25 | -16.85% since 02/24/25 | +1.14% since 02/24/25 |
Low | 201.43 on 02/26/25 | 795.38 on 03/13/25 | 161.10 on 03/14/25 | 73.80 on 03/12/25 | 88.86 on 02/26/25 |
High | 218.66 on 03/10/25 | 935.63 on 03/03/25 | 169.99 on 03/04/25 | 93.80 on 02/25/25 | 97.37 on 03/07/25 |
3-Month | |||||
%Chg | +16.21% since 12/24/24 | +8.70% since 12/24/24 | +11.96% since 12/24/24 | -13.78% since 12/24/24 | -7.18% since 12/24/24 |
Low | 168.06 on 01/22/25 | 725.01 on 01/17/25 | 140.68 on 01/10/25 | 73.80 on 03/12/25 | 81.04 on 02/18/25 |
High | 218.66 on 03/10/25 | 935.63 on 03/03/25 | 169.99 on 03/04/25 | 93.80 on 02/25/25 | 102.97 on 01/07/25 |
6-Month | |||||
%Chg | +8.09% since 09/24/24 | -6.44% since 09/24/24 | +0.31% since 09/24/24 | -39.95% since 09/24/24 | -19.70% since 09/24/24 |
Low | 163.81 on 11/19/24 | 711.40 on 11/18/24 | 140.68 on 01/10/25 | 73.80 on 03/12/25 | 81.04 on 02/18/25 |
High | 218.66 on 03/10/25 | 939.30 on 09/25/24 | 169.99 on 03/04/25 | 127.61 on 09/25/24 | 116.02 on 09/25/24 |
Key Statistics | |||||
Market Capitalization, $K | 370,742,208 | 794,158,720 | 394,323,456 | 344,911,712 | 235,199,200 |
Shares Outstanding, K | 1,765,355 | 948,170 | 2,409,848 | 4,487,532 | 2,526,036 |
Annual Sales | 56,334,000,000 | 45,042,700,000 | 88,821,000,000 | 42,108,430,000 | 64,168,000,000 |
Annual Net Income | 4,278,000,000 | 10,590,000,000 | 14,066,000,000 | 14,643,260,000 | 17,117,000,000 |
Last Quarter Sales | 15,102,000,000 | 13,532,800,000 | 22,520,000,000 | 12,261,320,000 | 15,624,000,000 |
Last Quarter Net Income | -22,000,000 | 4,409,800,000 | 3,431,000,000 | 4,026,620,000 | 3,743,000,000 |
60-Month Beta | 0.61 | 0.34 | 0.47 | 0.42 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | 2.16 on 01/31/25 | 5.32 on 02/06/25 | 2.04 on 01/22/25 | 0.91 on 02/05/25 | 1.72 on 02/04/25 |
Latest Earnings Date | 04/25/25 | 04/29/25 | 04/15/25 | 05/01/25 | 04/24/25 |
Most Recent Dividend | 1.640 on 01/15/25 | 1.500 on 02/14/25 | 1.240 on 02/18/25 | 0.362 on 08/16/24 | 0.810 on 03/17/25 |
Next Ex-Dividends Date | 04/15/25 | 02/14/25 | 02/18/25 | 03/31/25 | 03/17/25 |
Ratios | |||||
Price/Earnings ttm | 20.94 | 64.81 | 16.32 | 23.95 | 12.40 |